All you need to know about the battle over COVID jab IP rights

In a potentially pivotal move, the US has backed a global waiver on patent protections for coronavirus vaccines.

This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.

Accept Learn more…